Citation

Barbieri FA, Simieli L, Orcioli-Silva D, Baptista AM, Borkowske Pestana M, Spiandor Beretta V, dos Santos PCR, Bucken Gobbi LT. J. Mot. Behav. 2018; 50(1): 17-25.

Affiliation

Posture and Gait Studies Laboratory (LEPLO), Bioscience Institute, Department of Physical Education , Universidade Estadual Paulista-UNESP , Rio Claro , Brazil.

Copyright

(Copyright © 2018, Informa - Taylor and Francis Group)

DOI

10.1080/00222895.2016.1271303

PMID

28632105

Abstract

The authors' aim was to investigate gait asymmetry of crossing step during obstacle avoidance while walking in people with Parkinson's disease (PD) under and without the effects of dopaminergic medication. Thirteen individuals with PD and 13 neurologically healthy individuals performed 5 trials of unobstructed gait and 10 trials of obstacle crossing during gait (5 trials with each leg) and spatiotemporal parameters were analyzed. Obstacle crossing increased step duration of the crossing step for the most-affected or nondominant limb compared to the crossing step with the least-affected or dominant limb. Individuals with PD without the effects of medication increased step duration for the step with the least-affected limb compared to the step with the most-affected limb during obstacle crossing.

Language: en

Keywords

asymmetry; dopaminergic medication; gait; obstacle avoidance